Multimarker Approach Predicts Adverse Cardiovascular Events in Women Evaluated for Suspected Ischemia: Results from the National Heart, Lung, and Blood Institute–Sponsored Women's Ischemia Syndrome Evaluation

Inflammatory marker and hemoglobin levels (eg biomarkers) considered separately, predict adverse events in selected populations.A multiple biomarker approach predicts adverse events in women referred for evaluation of ischemia.We investigated associations between biomarkers (high sensitivity C-reactive protein, interleukin-6, serum amyloid-A, and hemoglobin levels) with adverse outcomes in women referred for coronary angiography for suspected...